Riskpilot← Back to searchSign inGet full accessEDERAGEN AS
ASActiveOrg 920202993Litleåsvegen 13, 5132 NyborgEngineering activities and related technical consultancy · NACE 7112Est. 20185 employees
Revenue 2024
NOK 2,4M
+1102% vs 2023
EBITDA margin
-41.8%
+54% vs 2023
Equity ratio
21.2%
Financial strength
Net profit 2024
NOK -1M
+54% vs 2023
| Revenue | NOK 2,4M | +1102% |
| EBITDA | NOK -1M | +54% |
| Net profit | NOK -1M | +54% |
| Total assets | NOK 3,8M | +4% |
| Equity | NOK 797K | -56% |
| Employees | 5 | — |
Legal name
EDERAGEN AS
Org number
920202993
Legal form
Aksjeselskap
NACE code
7112 · Engineering activities and related technical consultancy
Founded
10. januar 2018
Share capital
NOK 2 906 505
Employees
5 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Company purpose
Kommersialisere forskningsbasert kunnskap og kompetanse innen biosvitenskaper, og å drive næringsvirksomhet i den forbindelse, herunder deltakelse i andre selskaper.
Address
Litleåsvegen 13, 5132 Nyborg
Phone
+4791365943
Email
mail@ederagen.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 27 | 727 | 388 | 203 | 2 443 |
| Staff expenses | −1 882 | −2 088 | −1 609 | −1 576 | −1 808 |
| EBITDA | −2 772 | −2 324 | −2 570 | −2 202 | −1 020 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −2 772 | −2 324 | −2 570 | −2 202 | −1 020 |
| Net financials | 2 | 1 | 1 | 0 | 0 |
| Profit before tax | −2 770 | −2 323 | −2 570 | −2 202 | −1 020 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −2 770 | −2 323 | −2 570 | −2 202 | −1 020 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 846 | 2 746 | 3 762 | 3 616 | 3 751 |
| Equity | 1 089 | 866 | 1 919 | 1 817 | 797 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 757 | 1 880 | 1 843 | 1 799 | 2 954 |
| Total debt | 757 | 1 880 | 1 843 | 1 799 | 2 954 |
EBITDA margin
-41.8%
This company
15.8%
Market median
-365% vs market
20202024
Equity ratio
21.2%
This company
38.2%
Market median
-45% vs market
20202024
Return on equity
-128.0%
This company
18.4%
Market median
-796% vs market
20202024
Net profit margin
-41.8%
This company
8.1%
Market median
-616% vs market
20202024
Asset turnover
0.65×
This company
1.12×
Market median
-42% vs market
20202024
Debt / equity
3.71×
This company
0.62×
Market median
-498% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
JR | Chairman | 2018 |
| Board of Directors | 2024 | |
| Board of Directors | 2025 | |
| Former (1) | ||
| Board of Directors | 2018 – 2024 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 33.43% | 33.43% | 2024 | |
| Individual | 0.07% | 0.07% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Valand Invest As
EDERAGEN AS Board members of EDERAGEN AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jon Trygve Marthinsen | Board of Directors | 0 companies |
| Jan Raa | Chairman | 0 companies |
| Einar Andersen Martens | Board of Directors | 0 companies |
| Audun Lyche Nordli | Board of Directors | 0 companies |